发明名称 Indole carboxamide derivatives and uses thereof
摘要 A compound of Formula (I) is provided that has been shown to be useful for treating a disease, disorder or syndrome that is mediated by the transportation of essential molecules in the mmpL3 pathway:; wherein R1, R2, R3, R4, R5 and R6 are as defined herein.
申请公布号 US9447039(B2) 申请公布日期 2016.09.20
申请号 US201314420074 申请日期 2013.09.05
申请人 Novartis AG 发明人 Jiricek Jan;Kondreddi Ravinder Reddy;Smith Paul William
分类号 C07D209/12;C07D209/42;A61K31/4045;A61K31/407;A61K31/454;A61K31/5377;A61K45/06;C07D491/056 主分类号 C07D209/12
代理机构 Genomics Institute of the Novartis Research Foundation 代理人 Smith Chihang Amy;Genomics Institute of the Novartis Research Foundation
主权项 1. A compound of Formula (I)wherein: R1 is H; R2 is H, methyl, trifluoromethyl, chloro, bromo, fluoro, or cyano; R3 is H; R4 is H, methyl, trifluoromethyl, chloro, bromo, fluoro, cyano, or (phenyl)NH—; R5 is H or chloro;provided that R2, R3, R4 and R5 are not all hydrogen; R6 is (C5-C7)cycloalkyl or —CH2-(cyclohexyl), where said (C5-C7)cycloalkyl is optionally substituted with one to two substituents each independently selected from halo, methyl, isopropyl, fluoro-substituted methyl, and ethynyl, provided that R6 is not an unsubstituted cyclohexyl, when R2 and R4 are both methyl; or a pharmaceutically acceptable salt thereof.
地址 Basel CH